24 related articles for article (PubMed ID: 265013)
1. Markers in gynaecological cancer.
Bagshawe KD; Wass M; Searle F
Arch Gynecol; 1980; 229(4):303-10. PubMed ID: 7191243
[No Abstract] [Full Text] [Related]
2. Products of gynaecological neoplasms: clinical and pathological applications.
Neville AM
Arch Gynecol; 1980; 229(4):311-23. PubMed ID: 6158296
[TBL] [Abstract][Full Text] [Related]
3. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].
Kato T; Nishimura H; Hamai J; Yamabe T; Nakajima H; Nakano T; Noda K; Teshima K; Suzuki H; Ueda G
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2338-45. PubMed ID: 3007640
[No Abstract] [Full Text] [Related]
5. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
Bhattacharya M; Barlow JJ; Chu TM; Piver MS
Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
[No Abstract] [Full Text] [Related]
7. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
8. Tumor marker in ovarian cancer. Tumor-associated antigen.
Barlow JJ; Bhattacharya M
N Y State J Med; 1977 Mar; 77(3):342-3. PubMed ID: 265013
[No Abstract] [Full Text] [Related]
9. Ovarian tumor antigens.
Benson MD; Lurain JR; Newton M
J Reprod Med; 1983 Jan; 28(1):17-23. PubMed ID: 6187917
[TBL] [Abstract][Full Text] [Related]
10. [Immunology of malignant ovarian tumors. I. Familial occurrence, antigens and specific immunity].
Markowska J
Ginekol Pol; 1984 Sep; 55(9):695-700. PubMed ID: 6398791
[No Abstract] [Full Text] [Related]
11. The quest for a clearer understanding of ovarian carcinoma.
Beecham JB; Knauf SS
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1099-101. PubMed ID: 7028697
[No Abstract] [Full Text] [Related]
12. Monoclonal antibodies and their usefulness in epithelial ovarian cancer. A review.
Crowther ME; Britton KE; Granowska M; Shepherd JH
Br J Obstet Gynaecol; 1989 May; 96(5):516-21. PubMed ID: 2667627
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
